Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope

American Journal of Cardiology

Volumn 92, Issue 1, 2003, Pages 82-84

  Alegria, Jorge R ^a   Gersh, Bernard J ^a   Scott, Christopher G ^a   Hodge, David O ^a   Hammill, Stephen C ^a   Shen, Win Kuang ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PINDOLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYNCOPE;

EID: 0037861879     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00475-2     Document Type: Article

References (15)

1. Fenton A.M., Hammill S.C., Rea R.F., Low P.A., Shen W.K. Vasovagal syncope. Ann Intern Med. 133:2000;714-725.
2. Almquist A., Goldenberg I.F., Milstein S., Chen M.Y., Chen X.C., Hansen R., Gornick C.C., Benditt D.G. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 320:1989;346-351.
3. Benditt D.G., Goldstein D.S., Adler S., Sakaguchi S., Lurie K.G. Neurally mediated syncopal syndromes pathophysiology and clinical evaluation . Mandel W.J. Cardiac Arrhythmias Their Mechanisms, Diagnosis, and Management . 3rd Ed: 1995;879-906 JB Lippincott Company, Philadelphia.
4. Brignole M., Menozzi C., Gianfranchi L., Lolli G., Bottoni N., Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol. 70:1992;339-342.
5. Mahanonda N., Bhuripanyo K., Kangkagate C., Wansanit K., Kulchot B., Nademanee K., Chaithiraphan S. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J. 130:1995;1250-1253.
6. Biffi M., Boriani G., Sabbatani P., Bronzetti G., Frabetti L., Zannoli R., Branzi A., Magnani B. Malignant vasovagal syncope a randomised trial of metoprolol and clonidine . Heart. 77:1997;268-272.
7. Jhamb D.K., Singh B., Sharda B., Kaul U., Goel P., Talwar K.K., Wasir H.S. Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response. Am Heart J. 132:1996;608-611.
8. Scott W.A., Pongiglione G., Bromberg B.I., Schaffer M.S., Deal B.J., Fish F.A., Dick M. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol. 76:1995;400-402.
9. Fitzpatrick A.P., Ahmed R., Williams S., Sutton R. A randomized trial of medical therapy in "malignant vasovagal syndrome" or "neurally-mediated bradycardia hypotension syndrome" Eur J Cardiac Pacing Electrophysiol. 2:1991;99-102.
10. Madrid A.H., Ortega J., Rebollo J.G., Manzano J.G., Segovia J.G., Sanchez A., Pena G., Moro C. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population a prospective, double-blind, randomized and placebo-controlled study . J Am Coll Cardiol. 37:2001;554-559.
11. Flevari P., Livanis E.G., Theodorakis G.N., Zarvalis E., Mesiskli T., Kremastinos D.T. Vasovagal syncope a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being . J Am Coll Cardiol. 40:2002;499-504.
12. Sheldon R., Rose S., Flanagan P., Koshman M.L., Killam S. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol. 78:1996;536-539.
13. Cox M.M., Perlman B.A., Mayor M.R., Silberstein T.A., Levin E., Pringle L., Castellanos A., Myerburg R.J. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol. 26:1995;1293-1298.
14. Brignole M., Alboni P., Benditt D., Bergfeldt L., Blane J.S., Thomsen Bloch P.E., van Dijk J.G., Fitzpatrick A., Hohnloser S., Janousek J., et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 22:2001;1256-1306.
15. Dendi R., Goldstein D.S. Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope. Am J Cardiol. 89:2002;1319-1321.